30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

CNS Pharmaceuticals Inc (CNSP)

Track

Over the last 90 days, CNS Pharmaceuticals Inc. has seen one insider buy transaction totaling $34,001.9. This contrasts with earlier periods showing multiple buy transactions from executives and other insiders, alongside a few sell transactions from a single insider in March 2023. The stock has experienced significant price appreciation in the last 90 days.
Stock chart
Ticker: CNSP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Charles Faith L.
1 purchase — total 34,002 USD
Buy 18 May 2026
Value US$2,013,563.42 | Price 60.63 | Shares 264
Buy 1 Feb 2024
Value US$4,170,182.68 | Price 416.48 | Shares 19,380
Buy 1 Feb 2024
Value US$9,999.90 | Price 0.30 | Shares 33,333
Buy 1 Feb 2024
Value US$9,999.90 | Price 0.30 | Shares 33,333
Buy 1 Feb 2024
Value US$49,999.80 | Price 0.30 | Shares 166,666
Buy 22 Aug 2023
Value US$34,176.60 | Price 1.27 | Shares 27,000
Buy 16 Aug 2023
Value US$4,944.50 | Price 1.80 | Shares 2,750
Buy 19 Apr 2023
Value US$4,250.00 | Price 1.70 | Shares 2,500
Buy 17 Apr 2023
Value US$9,920.00 | Price 3.20 | Shares 3,100
Buy 12 Apr 2023
Value US$10,408.50 | Price 0.69 | Shares 15,000
Buy 10 Apr 2023
Value US$5,308.02 | Price 0.74 | Shares 7,173
Sale 28 Mar 2023
Value US$10,400.00 | Price 1.04 | Shares 10,000
Sale 27 Mar 2023
Value US$5,450.00 | Price 1.09 | Shares 5,000
Sale 24 Mar 2023
Value US$5,400.00 | Price 1.08 | Shares 5,000
Sale 23 Mar 2023
Value US$10,800.00 | Price 1.08 | Shares 10,000
Sale 22 Mar 2023
Value US$5,400.00 | Price 1.08 | Shares 5,000
Sale 21 Mar 2023
Value US$5,500.00 | Price 1.10 | Shares 5,000
Sale 20 Mar 2023
Value US$5,400.00 | Price 1.08 | Shares 5,000
Sale 17 Mar 2023
Value US$5,650.00 | Price 1.13 | Shares 5,000
Sale 16 Mar 2023
Value US$6,200.00 | Price 1.24 | Shares 5,000
Sale 15 Mar 2023
Value US$6,100.00 | Price 1.22 | Shares 5,000
Sale 14 Mar 2023
Value US$6,750.00 | Price 1.35 | Shares 5,000
Sale 13 Mar 2023
Value US$6,500.00 | Price 1.30 | Shares 5,000
Sale 10 Mar 2023
Value US$6,450.00 | Price 1.29 | Shares 5,000
Sale 9 Dec 2022
Value US$6,799.14 | Price 2.43 | Shares 2,798
Sale 8 Dec 2022
Value US$13,200.00 | Price 2.40 | Shares 5,500
Sale 7 Dec 2022
Value US$13,530.00 | Price 2.46 | Shares 5,500
Sale 6 Dec 2022
Value US$13,585.00 | Price 2.47 | Shares 5,500
Buy 6 Dec 2021
Value US$4,701.50 | Price 0.94 | Shares 5,000
Buy 19 Nov 2021
Value US$5,191.65 | Price 1.15 | Shares 4,500
Buy 24 Aug 2020
Value US$289,680.00 | Price 2.04 | Shares 142,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-18 B Purchase
3.1
Charles Faith L.
Non-Executive Director
264 -20.3%
60.63
US$2,013,563 		264 -20.3% 60.63 US$2,013,563
2024-02-06 2024-02-01 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
19,380 -3.4%
416.48
US$4,170,183 		19,380 -3.4% 416.48 US$4,170,183
2024-02-06 2024-02-01 B Purchase
Evans Carl Anthony
Non-Executive Director
93,313 -16.5%
498.97
US$4,084,052 		93,313 -16.5% 498.97 US$4,084,052
2024-02-06 2024-02-01 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
33,333 +344.6%
0.30
US$10,000 		33,333 +344.6% 0.30 US$10,000
2024-02-06 2024-02-01 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
166,666 +340.1%
0.30
US$50,000 		166,666 +340.1% 0.30 US$50,000
2023-08-23 2023-08-22 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
27,000 +276.3%
1.27
US$34,177 		27,000 +276.3% 1.27 US$34,177
2023-08-16 2023-08-16 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
2,750 +5.9%
1.80
US$4,944 		2,750 +5.9% 1.80 US$4,944
2023-04-21 2023-04-19 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
2,500 +34.9%
1.70
US$4,250 		2,500 +34.9% 1.70 US$4,250
2023-04-18 2023-04-17 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
3,100 +50.4%
3.20
US$9,920 		3,100 +50.4% 3.20 US$9,920
2023-04-14 2023-04-12 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
15,000 +50.0%
0.69
US$10,408 		15,000 +50.0% 0.69 US$10,408
2023-04-17 2023-04-10 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
7,173 +inf%
0.74
US$5,308 		7,173 +inf% 0.74 US$5,308
2023-08-01 2023-03-28 S Sale
1.6
Priebe Waldemar
Large shareholder
10,000 -6.0%
1.04
US$10,400 		10,000 -6.0% 1.04 US$10,400
2023-08-01 2023-03-27 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.9%
1.09
US$5,450 		5,000 -2.9% 1.09 US$5,450
2023-08-01 2023-03-24 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.8%
1.08
US$5,400 		5,000 -2.8% 1.08 US$5,400
2023-08-01 2023-03-23 S Sale
1.6
Priebe Waldemar
Large shareholder
10,000 -5.4%
1.08
US$10,800 		10,000 -5.4% 1.08 US$10,800
2023-08-01 2023-03-22 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.6%
1.08
US$5,400 		5,000 -2.6% 1.08 US$5,400
2023-08-01 2023-03-21 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.5%
1.10
US$5,500 		5,000 -2.5% 1.10 US$5,500
2023-08-01 2023-03-20 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.5%
1.08
US$5,400 		5,000 -2.5% 1.08 US$5,400
2023-08-01 2023-03-17 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.4%
1.13
US$5,650 		5,000 -2.4% 1.13 US$5,650
2023-08-01 2023-03-16 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.4%
1.24
US$6,200 		5,000 -2.4% 1.24 US$6,200
2023-08-01 2023-03-15 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.3%
1.22
US$6,100 		5,000 -2.3% 1.22 US$6,100
2023-08-01 2023-03-14 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.3%
1.35
US$6,750 		5,000 -2.3% 1.35 US$6,750
2023-08-01 2023-03-13 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.2%
1.30
US$6,500 		5,000 -2.2% 1.30 US$6,500
2023-08-01 2023-03-10 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.2%
1.29
US$6,450 		5,000 -2.2% 1.29 US$6,450
2023-08-01 2022-12-09 S Sale
1.6
Priebe Waldemar
Large shareholder
2,798 -1.2%
2.43
US$6,799 		2,798 -1.2% 2.43 US$6,799
2023-08-01 2022-12-08 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.3%
2.40
US$13,200 		5,500 -2.3% 2.40 US$13,200
2023-08-01 2022-12-07 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.2%
2.46
US$13,530 		5,500 -2.2% 2.46 US$13,530
2023-08-01 2022-12-06 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.2%
2.47
US$13,585 		5,500 -2.2% 2.47 US$13,585
2021-12-07 2021-12-06 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
5,000 +3.4%
0.94
US$4,702 		5,000 +3.4% 0.94 US$4,702
2021-11-22 2021-11-19 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
4,500 +3.2%
1.15
US$5,192 		4,500 +3.2% 1.15 US$5,192
2020-08-25 2020-08-24 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
142,000 +inf%
2.04
US$289,680 		142,000 +inf% 2.04 US$289,680
Explore more

More insider trading research around CNS Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America